The Effect of Malnutrition on the Pharmacokinetics of Phenylbutazone
- 1 January 1981
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 6 (2) , 152-159
- https://doi.org/10.2165/00003088-198106020-00005
Abstract
The pharmacokinetics of Phenylbutazone were studied after a single oral dose of 6mg/kg bodyweighl in 35 adult male subjects with differing nutritional status. The elimination half-life was significantly shorter and plasma clearance accelerated in undernourished patients who had significant weight deficit and low serum albumin concentration. Plasma protein binding was only 86% compared with 95 to 96% in normal subjects (smokers and non-smokers). The apparent volume of distribution was also higher in undernourished patients. Significant correlations were observed between serum albumin, protein binding and bodyweight. Multiple regression analysis of the data indicated that altered drug protein binding partially contributed towards variation in half-life and clearance; and the plasma albumin concentration significantly influenced the amount of drug bound in plasma. The results indicate that nutritional status is one of the important environmental variables that can alter drug kinetics and disposition in man. Further studies, including measurement of steady-stale plasma concentrations of various other drugs, are necessary to elucidate drug kinetics in malnourished subjects.This publication has 22 references indexed in Scilit:
- Penicillin pharmacokinetics in kwashiorkorThe American Journal of Clinical Nutrition, 1979
- Metabolism of sulphadiazine in malnutrition.Published by Wiley ,1979
- Effect of plasma protein and tissue binding on the biologic half‐life of drugsClinical Pharmacology & Therapeutics, 1978
- Clinical Pharmacokinetics of PhenylbutazoneClinical Pharmacokinetics, 1978
- Nutrition and drug‐metabolizing enzymesClinical Pharmacology & Therapeutics, 1977
- Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.BMJ, 1977
- Disposition and oxidative metabolism of phenylbutazone in manEuropean Journal of Clinical Pharmacology, 1977
- MECHANISM OF HEPATIC DRUG OXIDATION AND ITS RELATIONSHIP TO INDIVIDUAL DIFFERENCES IN RATES OF OXIDATION IN MAN*Annals of the New York Academy of Sciences, 1971
- Genetic Control of Drug Levels in Man: PhenylbutazoneScience, 1968
- THE METABOLIC FATE OF PHENYLBUTAZONE (BUTAZOLIDIN) IN MAN1955